.jpg)
Concentra swoops in to buy struggling Allakos, softening the blow of other denied buyout attempts
Tang Capital Partners-owned Concentra inked an Allakos acquisition agreement after its other buyout attempts were blocked by Pliant Therapeutics and Acelyrin earlier this year.
Tang Capital Partners-owned Concentra inked an Allakos acquisition agreement after its other buyout attempts were blocked by Pliant Therapeutics and Acelyrin earlier this year.
